Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 6, 2000, Pages 1999-2004

  Marshall, Richard P ^a,b   McAnulty, Robin J ^a   Laurent, Geoffrey J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; MITOGENIC AGENT; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; AUTOCRINE EFFECT; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FETUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LUNG FIBROBLAST; LUNG FIBROSIS; MESENCHYME; MITOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034047028     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.6.9907004     Document Type: Article

References (40)

1. 1. Linz, W., B. A. Scholkens, and D. Ganten. 1989. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. 11:1325-1350.
2. 2. Cohen, E. P., A. Molteni, P. Hill, B. L. Fish, W. F. Ward, J. E. Moulder, and F. A. Carone. 1996. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab. Invest. 75:349-360.
3. 3. Sheiban, I., G. Arcaro, G. Covi, R. Accardi, C. Zenorini, and A. Lechi. 1987. Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril. J. Cardiovasc. Pharmacol. 10(Suppl.): S187-S191.
4. 4. Baker, K. M., M. I. Chernin, S. K. Wixson, and J. F. Aceto. 1990. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259:H324-H332.
5. 5. Lieberman, J. 1975. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am. J. Med. 59:365-372.
6. 6. Specks, U., W. J. Martin, 2d, and M. S. Rohrbach. 1990. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am. Rev. Respir. Dis. 141:117-123.
7. 7. Gronhagen-Riska, C., K. Kurppa, F. Fyhrquist, and O. Selroos. 1978. Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand. J. Respir. Dis. 59:228-231.
8. 8. Idell, S., F. Kueppers, M. Lippmann, H. Rosen, M. Niederman, and A. Fein. 1987. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 91:52-56.
9. 9. Fourrier, F., C. Chopin, B. Wallaert, C. Mazurier, J. Mangalaboyi, and A. Durocher. 1985. Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 87:191-195.
10. 10. Campbell, D. J., A. Kladis, and A. J. Valentijn. 1995. Effects of Losartan on angiotensin and bradykinin peptides and angiotensin converting enzyme. J. Cardiovasc. Pharmacol. 26:233-240.
11. 11. Song, L., D. Wang, X. Cui, Z. Shi, and H. Yang. 1998. Kinetic alterations of angiotensin-II and nitric oxide in radiation pulmonary fibrosis. J. Environ. Pathol. Toxicol. Oncol. 17:141-150.
12. 12. Cassis, L., U. Shenoy, D. Lipke, J. Baughn, M. Fettinger, and M. Gillespie. 1997. Lung angiotensin receptor binding characteristics during the development of monocrotaline-induced pulmonary hypertension. Biochem. Pharmacol. 54:27-31.
13. 13. Campbell, D. J., and J. F. Habener. 1989. Hybridization in situ studies of angiotensinogen gene expression in rat adrenal and lung. Endocrinology 124:218-222.
14. 14. Entzeroth, M., and S. Hadamovsky. 1991. Angiotensin II receptors in the rat lung are of the AH-1 subtype. Eur. J. Pharmacol. 206:237-241.
15. 15. Ko, Y., H. Stiebler, G. Nickenig, A. J. Wieczorek, H. Vetter, and A. Sachinidis. 1993. Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells. Am. J. Hypertens. 6:496-499.
16. 16. Villarreal, F. J., N. N. Kim, G. D. Ungab, M. P. Printz, and W. H. Dillmann. 1993. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 88:2849-2861.
17. 17. Tsutsumi, Y., H. Matsubara, N. Ohkubo, Y. Mori, Y. Nozawa, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Moriguchi, Y. Shibasaki, H. Kamihata, M. Inada, and T. Iwasaka. 1998. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ. Res. 83:1035-1046.
18. 18. Wharton, J., K. Morgan, R. A. Rutherford, J. D. Catravas, A. Chester, B. F. Whitehead, M. R. De Leval, M. H. Yacoub, and J. M. Polak. 1998. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J. Pharmacol. Exp. Ther. 284:323-336.
19. 19. Hall, K. L., S. Venkateswaran, J. M. Hanesworth, M. E. Schelling, and J. W. Harding. 1995. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul. Pept. 58: 107-115.
20. 20. Ruiz-Ortega, M., O. Lorenzo, and J. Egido. 1998. Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts. Kidney Int. Suppl. 68:S41-S45.
21. 21. Koibuchi, Y., W. S. Lee, G. H. Gibbons, and R. E. Pratt. 1993. Role of transforming growth factor-beta 1 in the cellular growth response to angiotensin II. Hypertension 21:1046-1050.
22. 22. Hahn, A. W., T. J. Resnik, F. Kern, and F. R. Buhler. 1993. Peptide vasoconstrictors, vessel structure and vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 22:S37-S43.
23. 23. Lee, A. A., W. H. Dillmann, A. D. McCulloch, and F. J. Villarreal. 1995. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J. Mol. Cell. Cardiol. 27:2347-2357.
24. 24. Hoyt, D. G., and J. S. Lazo. 1988. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246:765-771.
25. 25. Coker, R. K., G. J. Laurent, S. Shahzeidi, P. A. Lympany, R. M. du Bois, P. K. Jeffery, and R. J. McAnulty. 1997. Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am. J. Pathol. 150:981-991.
26. 26. Roberts, A. B., M. B. Sporn, R. K. Assoian, J. M. Smith, N. S. Roche, L. M. Wakefield, U. I. Heine, L. A. Liotta, V. Falanga, and J. H. Kehrl. 1986. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83:4167-4171.
27. 27. McAnulty, R. J., N. A. Hernandez-Rodriguez, S. E. Mutsaers, R. K. Coker, and G. J. Laurent. 1997. Indomethacin suppresses the antiproliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem. J. 321:639-643.
28. 28. Smith, R. 1993. Identification of AT2 angiotensin receptors on swiss 3T3 cells. Biochem. Mol. Biol. Int. 31:975-982.
29. 29. Herbet, J., C. Delisee, F. Dol, P. Schaeffer, C. Cazaubon, D. Nisato, and P. Chatelain. 1994. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro. Eur. J. Pharmacol. 251:143-150.
30. 30. Ohkubo, N., H. Matsubara, Y. Nozawa, Y. Mori, S. Murasawa, K. Kijima, K. Maruyama, H. Masaki, Y. Tsutumi, Y. Shibazaki, T. Iwasaka, and M. Inada. 1997. Angiotensin type 2 receptors are reexpressed by cardiac fibroblast from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 96:3954-3962.
31. 31. Tsuzuki, S., T. Matoba, S. Eguchi, and T. Inagami. 1996. Angiotensin II type 2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension 28:916-918.
32. 32. Yamada, T., M. Horiuchi, and V. J. Dzau. 1996. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 93:156-160.
33. 33. Richard, D. E., L. Chretien, M. Caron, and G. Guillemette. 1997. Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway. Mol. Cell. Endocrinol. 129:209-218.
34. 34. Katwa, L. C., S. E. Campbell, S. C. Tyagi, S. J. Lee, G. T. Cicila, and K. T. Weber. 1997. Cultured myofibroblasts generate angiotensin peptides de novo. J. Mol. Cell. Cardiol. 29:1375-1386.
35. 35. Giri, S. N., D. M. Hyde, and M. A. Hollinger. 1993. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice [see Comments]. Thorax 48:959-966.
36. 36. Siegert, A., E. Ritz, S. Orth, and J. Wagner. 1999. Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor beta in vascular smooth muscle. J. Mol. Med. 77:437-445.
37. 37. Ford, C. M., S. Li, and J. G. Pickering. 1999. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells: involvement of the AT (1) receptor, TGF-beta and tyrosine phosphorylation. Atherioscler. Thromb. Vasc. Biol. 19:1843-1851.
38. 38. Wolf, G., E. Mueller, R. A. Stahl, and F. N. Ziyadeh. 1993. Angiotensin-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor beta. J. Clin. Invest. 92:1366-1372.
39. 39. Lindberg, B. F., E. Gyllstedt, and K. E. Andersson. 1997. Conversion of angiotensin I to angiotensin II by chymase activity in human pulmonary membranes. Peptides 18:847-853.
40. 40. Okabe, T., K. Yamagata, M. Fujisawa, J. Watanabe, F. Takaku, J. J. Lanzillo, and B. L. Fanburg. 1985. Increased angiotensin-converting enzyme in peripheral blood monocytes from patients with sarcoidosis. J. Clin. Invest. 75:911-914.